Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia
Shanchol™, a WHO-prequalified oral cholera vaccine (OCV), has been used to control endemic cholera in Asia, as well as in emergencies and outbreaks elsewhere. The vaccine has not been used by public health systems in cholera-endemic settings of Africa although several outbreak response campaigns hav...
Saved in:
Main Authors: | Samuel Teshome (Author), Sachin Desai (Author), Jerome H. Kim (Author), Dires Belay (Author), Vittal Mogasale (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral Cholera Vaccination Delivery Cost in Low- and Middle-Income Countries: An Analysis Based on Systematic Review.
by: Vittal Mogasale, et al.
Published: (2016) -
Costing oral cholera vaccine delivery using a generic oral cholera vaccine delivery planning and costing tool (CholTool)
by: Winthrop Morgan, et al.
Published: (2020) -
An overview of VaxchoraTM, a live attenuated oral cholera vaccine
by: Tarun Saluja, et al.
Published: (2020) -
Cost of conducting Measles-Rubella vaccination campaign in India
by: Susmita Chatterjee, et al.
Published: (2022) -
Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.
by: Christian Schaetti, et al.
Published: (2012)